BRIEF-Fennec qtrly loss per share $0.04
May 12 (Reuters) - Fennec Pharmaceuticals Inc :
* Qtrly loss per share $0.04
* Entered into agreement with elion oncology involving transfer by fennec of intellectual property, data relating to eniluracil
* Agreement for transfer by co of intellectual property relating to eniluracil,adh-1 technologies,development programs to elion
* Fennec provides corporate update and announces first quarter 2016 results Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.